Cargando…
Association between antidementia medication use and mortality in people diagnosed with dementia with Lewy bodies in the UK: A retrospective cohort study
BACKGROUND: Dementia with Lewy bodies (DLBs) is a common cause of dementia but has higher mortality than Alzheimer’s disease (AD). The reasons for this are unclear, but antidementia drugs (including acetylcholinesterase inhibitors [AChEIs] and memantine) symptomatically benefit people with DLB and m...
Autores principales: | Chen, Shanquan, Price, Annabel C., Cardinal, Rudolf N., Moylett, Sinéad, Kershenbaum, Anne D., Fitzgerald, James, Mueller, Christoph, Stewart, Robert, O’Brien, John T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725132/ https://www.ncbi.nlm.nih.gov/pubmed/36472984 http://dx.doi.org/10.1371/journal.pmed.1004124 |
Ejemplares similares
-
Mortality rates are higher in lewy body and parkinson's disease dementia compared to Alzheimer's dementia in patients referred into a secondary care mental health service. Why?
por: K, Anne, et al.
Publicado: (2021) -
Mortality in dementia with Lewy bodies compared with Alzheimer’s dementia: a retrospective naturalistic cohort study
por: Price, Annabel, et al.
Publicado: (2017) -
Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications
por: Mueller, Christoph, et al.
Publicado: (2017) -
Investigation of risk of dementia diagnosis and death in patients in older people's secondary care mental health services
por: Kershenbaum, Anne, et al.
Publicado: (2020) -
The use of antidementia therapy in non-dementia cognitive disorders associated with COVID-19
por: Liubov, P., et al.
Publicado: (2023)